| 55 |
Urinary tissue factor (uTF), tissue factor pathway inhibitor (TFPI) and plasmin as novel biomarkers in early diagnosis of lupus nephritis. |
Internal Medicine |
2024 |
| 56 |
Validation of the arabic version of the EuroQol-5-dimension 5-level (EQ-5D-5 L) in patients with spinal degenerative diseases |
Department of Orthopedic Surgery and Traumatology |
2024 |
| 57 |
Evaluation of exercise capacity in chronic obstructive pulmonary disease patients with pulmonary hypertension |
Department of Chest Diseases |
2024 |
| 58 |
Influence of CYP2C8*3 and ABCG2 C421A genetic polymorphisms on trough concentration and molecular response of imatinib in Egyptian patients with chronic myeloid leukemia |
Department of Pharmacology |
2024 |
| 59 |
Predictors of post-kidney transplantation complications among Egyptian recipients—1-year follow-up |
Internal Medicine |
2024 |
| 60 |
Effect of non-alcoholic fatty liver disease on outcome of primary pci in non-diabetic stemi patients |
Department of Cardiology |
2024 |
| 61 |
Ameliorative effects of gallic acid on tebuconazole–induced adverse effects in the cerebellum of adult albino rats: histopathological and immunohistochemical evidence |
Department of Anatomy |
2024 |
| 62 |
Musculoskeletal utrasond findings in Jevenile idiopathic arthritis |
Department of Diagnostic Radiology |
2024 |
| 63 |
Epidemiology, Risk factors, Outcomes and role of Serpin A3 as a biomarker for Transition of Acute Kidney Injury to Chronic Kidney Disease in critically ill patients |
Internal Medicine |
2024 |
Do you have any questions? 
